Month: February 2023

Treatment for Presbyopia FDA Accepts Orasis Pharmaceuticals’ New Drug Application for CSF-1 for the Treatment of Presbyopia Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 Ponte Vedra, FL, February 21, 2023 – Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near
0 Comments
KING OF PRUSSIA, Pa., Feb. 26, 2023 /PRNewswire/ — Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today presented results from the pivotal placebo-controlled Phase 3 VANGUARD clinical trial of garadacimab (CSL312). Garadacimab is CSL’s investigational first-in-class monoclonal antibody being developed as a long-term prophylactic treatment for patients with hereditary angioedema (HAE). Results from the trial, the
0 Comments
Human milk (HM) is considered the gold standard for the nutrition of infants, as it provides several dietary benefits to the mother-infant dyads for both the short and long term. HM comprises various types of cells including leukocytes and epithelial cells; however, data on cellular diversity and phenotypic characteristics during lactation are limited. Study: Metabolomic Diversity
0 Comments
Intranasal corticosteroids (INCs) improved quality of life for children suffering from chronic rhinosinusitis, the RAISE randomized trial showed. Sinus and Nasal Quality of Life Survey (SN-5) scores improved significantly more for children assigned to daily intranasal mometasone spray (Nasonex) along with daily saline solution rinsing with a nasal nebulizer compared with the saline routine alone,
0 Comments
In a recent review published in Nutrients, researchers summarize existing literature on the effects of consuming nuts on biomarkers of inflammation and oxidative stress. Study: Effect of Nuts on Markers of Inflammation and Oxidative Stress: A Narrative Review. Image Credit: Shebeko / Shutterstock.com The health benefits of nuts Inflammation and oxidative stress mediate the pathophysiology of various non-communicable diseases.
0 Comments
You Can Get Cheap (But Suboptimal) Insulin at Walmart Without an RX – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may
0 Comments
Experts shared advice on diagnosis and treatment of children and adolescents showing signs of post-COVID conditions — also known as long COVID — during a CDC Clinician Outreach and Communication Activity (COCA) webinar. “Post-COVID conditions” is the preferred term of the CDC and is defined as “the wide range of physical and mental health consequences
0 Comments
Several digital therapeutics (DTx) — evidence-based interventions delivered via mobile app or web-based platforms — could help patients with irritable bowel syndrome (IBS), according to a new review of available products. These tools aren’t widely used by gastroenterologists yet, but the market is expected to grow broadly during the next decade. Dr William Chey “Digital
0 Comments
When Warren Buffett speaks, Wall Street listens — and the “Oracle of Omaha” issued a full-throated defense of stock buybacks in his latest annual letter to Berkshire Hathaway shareholders. That’s why we’re shining a light on the Club holdings that repurchase the most stock, including Morgan Stanley (MS), Meta Platforms (META) and Apple (AAPL). Buffett’s
0 Comments
Label expansion for Cibinqo provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis NEW YORK–(BUSINESS WIRE) February 10, 2023 — Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for Cibinqo® (abrocitinib), expanding its indication
0 Comments
JUPITER, Fla. and BOSTON, Feb. 27, 2023. Jupiter Neurosciences, Inc. (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of central nervous system (CNS) disorders and rare diseases, today announced topline proof-of-concept preclinical data with its proprietary resveratrol drug product, JOTROL, for Parkinson’s Disease (PD). In collaboration with scientists
0 Comments
A new brain connection discovered by University of California, Irvine researchers can explain how early-life stress and adversity trigger disrupted operation of the brain’s reward circuit, offering a new therapeutic target for treating mental illness. Impaired function of this circuit is thought to underlie several major disorders, such as depression, substance abuse and excessive risk-taking.
0 Comments
SAN ANTONIO — Among patients with hereditary angioedema (HAE), monthly injections of the investigational biologic garadacimab reduced the mean attack rate substantially in the phase III VANGUARD clinical trial. During the 6-month trial, the average monthly HAE attack rate dropped to 0.27 in the garadacimab group versus 2.01 for the placebo group (P<0.001), representing a
0 Comments
Ozempic and Side Effects: Nausea, Diarrhea, Vomiting… – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by third
0 Comments
Good work-life balance can sometimes feel elusive and unattainable, so we’re breaking it down into its six key pillars Poor work-life balance can snatch life’s joyous moments away from us, and be detrimental to our mental health and wellbeing. But levelling it out isn’t usually straightforward. Here, with the help of Dr Kirstie Fleetwood Meade,
0 Comments
Insomnia — difficulty falling or staying asleep — was associated with a 69% greater risk of having a myocardial infarction (MI) than among adults without insomnia, according to new research. Those who slept 5 or fewer hours per night had the highest risk for MI, and those with both diabetes and insomnia had double the
0 Comments